EGFR-IN-166
EGFR-IN-166 (Compound 2) is a EGFR inhibitor. EGFR-IN-166 has potent anticancer activity against breast cancer cells with IC50s of 69.63 and 22.84 μM for MCF-7 and MDA-MB-231 cells, respectively. EGFR-IN-166 significantly inhibits cell migration and EGFR expression. EGFR-IN-166 can be used for breast cancer research[1].
Product Specifications
CAS Number
503443-98-9
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C1CN(C2=CC=CC=C2)/C(S1)=C3C(C)=NN(C4=CC=CC=C4)C/3=O
Molecular Formula
C19H15N3O2S
Molecular Weight
349.41
References & Citations
[1]Mahmoud SE, et al. Discovery and molecular characterization of a potent thiazolyl-pyrazole hybrid targeting EGFR for breast cancer therapy. Sci Rep. 2025 Jul 3;15 (1) :23743.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY419077 100 µg
PCPTP1 (PTPRR) (NM_002849) Human Over-expression Lysate
Sign In for Pricing
View Details